| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.19B | 20.33B | 20.00B | 19.42B | 17.47B | 14.44B |
| Gross Profit | 6.49B | 6.76B | 6.09B | 5.61B | 4.99B | 3.28B |
| EBITDA | 3.37B | 3.54B | 3.35B | 3.07B | 2.89B | 1.58B |
| Net Income | 1.12B | 1.15B | 1.09B | 1.06B | 897.87M | -434.38M |
Balance Sheet | ||||||
| Total Assets | 55.87B | 56.89B | 56.45B | 56.72B | 56.79B | 56.77B |
| Cash, Cash Equivalents and Short-Term Investments | 2.55B | 2.62B | 2.66B | 2.71B | 2.49B | 2.52B |
| Total Debt | 25.65B | 25.53B | 26.68B | 27.76B | 29.48B | 30.66B |
| Total Liabilities | 36.65B | 36.70B | 37.42B | 38.63B | 39.81B | 40.50B |
| Stockholders Equity | 19.22B | 20.19B | 19.03B | 18.09B | 16.99B | 16.27B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.03B | 1.56B | 2.06B | 1.32B | 1.00B |
| Operating Cash Flow | 0.00 | 2.81B | 2.57B | 2.88B | 2.68B | 2.14B |
| Investing Cash Flow | 0.00 | -899.84M | -1.19B | -849.79M | -1.45B | -1.21B |
| Financing Cash Flow | 0.00 | -1.95B | -1.43B | -1.82B | -1.25B | -855.22M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | ¥7.49B | 6.68 | ― | 0.47% | 1.67% | 5.71% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | ¥219.51B | 7.11 | 12.70% | 1.68% | 6.91% | 58.68% | |
58 Neutral | ¥40.25B | -38.21 | ― | 2.58% | 7.30% | -28.80% | |
54 Neutral | ¥3.13B | 8.28 | ― | ― | 6.85% | 231.61% | |
54 Neutral | ¥19.39B | 13.17 | ― | 0.81% | 5.49% | 29.14% | |
50 Neutral | ¥18.46B | 16.20 | ― | 1.33% | 11.16% | -16.05% |